Tag: Lomb
Novartis sells ophthalmology assets to Bausch + Lomb for $2.5 billion
(Tiper Stock Exchange) – Novartisa Swiss multinational operating in the pharmaceutical sector, has signed a agreement for the sale of the ophthalmology business “front of eye” a Bausch + Lomba…
Bausch + Lomb, positive debut on the NYSE
(Finance) – Bausch + Lomba North American company active in the field of eye health, is landed today with the symbol “BLCO” on the New York Stock Exchange (NYSE) and…